Studies show the benefit of continuous glucose monitoring
Today, Onduo announced that they will present three abstracts to the American Diabetes Association (ADA) 80E Scientific Sessions: A virtual experiment, June 12-16, discussing the Onduo Virtual Diabetes Clinic that uses intermittent continuous glucose monitoring (CGM) in patients with type 2 diabetes.
In February, Onduo shared positive results from research on the use of CGM in adults with type 2 diabetes, with an overwhelming majority of survey participants (95% or more) reporting that the use of CGM has contributed to their knowledge of diabetes, including the impact of diet and medication.
Here are the details of the virtual abstract presentations that will provide the full clinical study data from this trial:
ADA Presidents -CloseCurlyQuote; Select Summary: Participation in a Virtual Diabetes Clinic and Reduction of Diabetes-Related Distress in People with Type 2 Diabetes
Presenter: Dr. Bill Polonsky
Time/Date: Friday, June 12 at 5 p.m. CT
Change in a1C with and without intermittent use of CGM in adults with type 2 diabetes Participant in the Onduo Virtual Diabetes Clinic
Presenter: Dr. Ronald Dixon
Time/Date: Saturday, June 13 at 9:45 a.m. CT
Improved A1C and TIR in adults with type 2 diabetes Participating in a CGM-focused virtual diabetes clinic
Presenter: Dr. Amit Majitia
Time/Date: Online available for registered participants
About Continuous Glucose Monitoring
CGM devices are small sensors, worn on the stomach, that take glucose readings every five minutes – automatically. Although MMs have always been used by people with type 1 diabetes, more recently, the value of MMMs has been recognized to help people living with type 2 manage their diabetes. Onduo pioneered the intermittent use of CMMs in its program in 2018, where members wore the device every few months for a period of 10 days to promote long-term engagement and sustainability. Intermittent use also allows the clinic to make periodic assessments as a person-CloseCurlyQuote;s changes in clinical condition.
Onduo is on a mission to provide people with the most up-to-date care — anytime, anywhere. Our virtual care model leverages in-depth analysis, connected devices, top-performing software and specialized care to provide a lifestyle and clinical interventions that can help people live their best lives. Launched as a joint venture in 2016, Onduo works closely with Verily Life Sciences (an Alphabet company) to build a team of talented people committed to creating a next-generation platform that will help people live well while managing their health holistically. Onduo-CloseCurlyQuote is headquartered in Newton, MA.
Copyright Business Wire 2020